Close
  Indian J Med Microbiol
 

Figure 3: Random effects model of the odds ratios (ORs) with 95% confidence intervals (CIs) of the association of BRAF mutation with tumor site; (b) fixed effects model of the odds ratios (ORs) with 95% confidence intervals (CIs) of the association of BRAF mutation with tumor differentiation; (c) fixed effects model of the odds ratios (ORs) with 95% confidence intervals (CIs) of the association of BRAF mutation with node involvement; (d) fixed effects model of the odds ratios (ORs) with 95% confidence intervals (CIs) of the association of BRAF mutation with tumor size; (e) fixed effects model of the odds ratios (ORs) with 95% confidence intervals (CIs) of the association of BRAF mutation with AJCC stage

Figure 3: Random effects model of the odds ratios (ORs) with 95% confidence intervals (CIs) of the association of <i>BRAF</i> mutation with tumor site; (b) fixed effects model of the odds ratios (ORs) with 95% confidence intervals (CIs) of the association of <i>BRAF</i> mutation with tumor differentiation; (c) fixed effects model of the odds ratios (ORs) with 95% confidence intervals (CIs) of the association of <i>BRAF</i> mutation with node involvement; (d) fixed effects model of the odds ratios (ORs) with 95% confidence intervals (CIs) of the association of <i>BRAF</i> mutation with tumor size; (e) fixed effects model of the odds ratios (ORs) with 95% confidence intervals (CIs) of the association of <i>BRAF</i> mutation with AJCC stage